SBIR-STTR Award

A Cost-effective, Large Scale and a Novel Synthetic Route for Quasi-2D MXene's Phase
Award last edited on: 2/8/21

Sponsored Program
STTR
Awarding Agency
DOD : AF
Total Award Amount
$149,999
Award Phase
1
Solicitation Topic Code
AF18B-T017
Principal Investigator
Duraiswamy 'ravi' Ravichandran

Company Information

Texas Biochemicals Inc

2151 Harvey Mitchell Parkway South Suite 225
College Station, TX 77840
   (979) 696-7070
   info@texasbiochemicals.com
   www.texabiochemicals.com

Research Institution

Auburn University

Phase I

Contract Number: FA8650-19-P-5074
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2019
Phase I Amount
$149,999
MAX phases are an important class of layered machinable ternary carbides and nitrides that exhibit a unique combination of ceramic and metal properties. In 2011, a new family of two-dimensional (2D) transition metal carbides, nitrides, and carbonitrides – called MXenes – was discovered via selective etching of the ‘A’ element from MAX phases. Texas Biochemicals Inc., has recently developed a novel cost-effective and large-scale synthesis route for producing MXene compounds in-house. In the Phase-I project, Texas Biochemicals Inc. will advance the environmentally benign manufacturing technology for large scale production of cost-effective, high performance, superior quality MXenes. Specifically, we have targeted four MXene compositions that are electromagnetically responsive, electrically conductive and attractive for various emerging applications during this Phase-I project. Collaboration with a leading university with one of the co-inventor of MXene phase compounds and a prime contractor is established to evaluate samples and provide technical guidance. Their input described under Phase I tasks and the letter of support demonstrates their intention to become a commercialization partner leading to near term technology util

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----